Your browser doesn't support javascript.
loading
Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years.
Mwau, Matilu; Bwana, Priska; Kithinji, Lucy; Ogollah, Francis; Ochieng, Samuel; Akinyi, Catherine; Adhiambo, Maureen; Ogumbo, Fred; Sirengo, Martin; Boeke, Caroline.
Afiliação
  • Mwau M; Centre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.
  • Bwana P; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Kithinji L; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Ogollah F; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Ochieng S; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Akinyi C; Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Adhiambo M; Centre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.
  • Ogumbo F; Centre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.
  • Sirengo M; Centre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute, Busia, Kenya.
  • Boeke C; National AIDS and STIs Control Program, Ministry of Health, Nairobi, Kenya.
PLoS One ; 12(8): e0183860, 2017.
Article em En | MEDLINE | ID: mdl-28850581
ABSTRACT

OBJECTIVE:

To describe factors associated with mother-to-child HIV transmission (MTCT) in Kenya and identify opportunities to increase testing/care coverage.

DESIGN:

Cross-sectional analysis of national early infant diagnosis (EID) database.

METHODS:

365,841 Kenyan infants were tested for HIV from January 2007-July 2015 and results, demographics, and treatment information were entered into a national database. HIV risk factors were assessed using multivariable logistic regression.

RESULTS:

11.1% of infants tested HIV positive in 2007-2010 and 6.9% in 2014-2015. Greater odds of infection were observed in females (OR 1.08; 95% CI1.05-1.11), older children (18-24 months vs. 6 weeks-2 months 4.26; 95% CI3.87-4.69), infants whose mothers received no PMTCT intervention (vs. HAART OR 1.92; 95% CI1.79-2.06), infants receiving no prophylaxis (vs. nevirapine for 6 weeks OR 2.76; 95% CI2.51-3.05), and infants mixed breastfed (vs. exclusive breastfeeding OR 1.39; 95% CI1.30-1.49). In 2014-2015, 9.1% of infants had mothers who were not on treatment during pregnancy, 9.8% were not on prophylaxis, and 7.0% were mixed breastfed. Infants exposed to all three risky practices had a seven-fold higher odds of HIV infection compared to those exposed to recommended practices. The highest yield of HIV-positive infants were found through targeted testing of symptomatic infants in pediatric/outpatient departments (>15%); still, most infected infants were identified through PMTCT programs.

CONCLUSION:

Despite impressive gains in Kenya's PMTCT program, some HIV-infected infants present late and are not benefitting from PMTCT best practices. Efforts to identify these early and enforce evidence-based practice for PMTCT should be scaled up. Infant testing should be expanded in pediatric/outpatient departments, given high yields in these portals.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Infecções por HIV / Transmissão Vertical de Doenças Infecciosas / Fármacos Anti-HIV / Nevirapina / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Newborn / Pregnancy País/Região como assunto: Africa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Infecções por HIV / Transmissão Vertical de Doenças Infecciosas / Fármacos Anti-HIV / Nevirapina / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Newborn / Pregnancy País/Região como assunto: Africa Idioma: En Ano de publicação: 2017 Tipo de documento: Article